Sarah Oliver
Executive Director - Global Regulatory Oncology Head - Gilead
Leading the oncology portfolio at Gilead. Managing early and late stage innovative assets in IO and targeted therapy. Working with GRLs across the TA to develop assets. Leading work-stream on talent development for liaisons as well as preceptor to the Gilead Rotational Fellowship.